Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Many individuals seeking obesity treatment also exhibit BED of low frequency and/or limited duration (Dalle Grave, 2023)
Phentermine was developed as an appetite suppressant and approved for short-term use in 1959
While GLP-1 has been the heartthrob in the diabetes and weight loss world for years, GIP's potential has remained mainly in the shadows
Additionally, two small studies in participants presenting with antiretroviral-induced neuropathy found significant reduction in subjects' mean pain intensity with oral ALCAR (1-3 g/day) for 4 to 24 weeks, but no effect on objective neurophysiological parameters was found (82, 83)
The peptide's unique dual receptor mechanism, targeting both amylin (AMY1R, AMY2R, AMY3R) and calcitonin receptors (CTR), provides a novel approach to appetite regulation and metabolic control that goes beyond traditional GLP-1 therapies
